"10.1371_journal.pone.0090948","plos one","2014-03-26T00:00:00Z","David Britton; Yoh Zen; Alberto Quaglia; Stefan Selzer; Vikram Mitra; Christopher Lößner; Stephan Jung; Gitte Böhm; Peter Schmid; Petra Prefot; Claudia Hoehle; Sasa Koncarevic; Julia Gee; Robert Nicholson; Malcolm Ward; Leandro Castellano; Justin Stebbing; Hans Dieter Zucht; Debashis Sarker; Nigel Heaton; Ian Pike","Proteome Sciences plc, Cobham, United Kingdom; Institute of Liver Studies, Kings College Hospital, London, United Kingdom; Faculty of Medicine, Department of Surgery & Cancer, Imperial College, London, United Kingdom; Cardiff School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom","Conceived and designed the experiments: DB IP YZ AQ NH MW. Performed the experiments: DB YZ CL SJ GB PS PP CH SK LC. Analyzed the data: DB YZ SS CL VM SK HDZ IP. Contributed reagents/materials/analysis tools: YZ AQ JG RN LC JS DS NH. Wrote the paper: DB YZ AQ SS CL SJ GB LC JS NH IP.","We have the following interests. This study was partly funded by Proteome Sciences plc, the employer of David Britton, Stefan Selzer, Vikram Mitra, Christopher Lößner, Stephan Jung, Gitte Böhm, Peter Schmid, Petra Prefot, Claudia Hoehle, Sasa Koncarevic, Malcolm Ward, Hans Dieter Zucht and Ian Pike. All employees of Proteome Sciences plc (except newly recruited Vikram Mitra) hold stock or stock options in Proteome Sciences plc. Proteome Sciences also produce the TMT reagents used in this study and these reagents are now licensed for distribution by Thermo Fisher Scientific. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","03","David Britton","DB",21,TRUE,6,10,8,11,TRUE,TRUE,FALSE,0,NA,FALSE
